Rahbar, K., Schlack, K., Boegemann, M., Kidd, M. S., Halim, A. B. (2026). Early changes in PROSTest, a blood-based mRNA assay, as a predictor of outcomes of
                    <sup>177</sup>
                    LuPSMA radioligand therapy and chemotherapy in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17067